Yarrow Bioscience, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New Haven, CT
YARW chart
What traders are saying about $YARW
Latest postsYarrow Bioscience, Inc. news
- Understanding Momentum Shifts in (YARW)
Stock Traders Daily ·
- Why is Yarrow Bioscience stock rallying today? By Investing.com
Investing.com Australia ·
- Guggenheim starts Yarrow Bioscience at Buy, citing Graves’ disease potential
Yahoo Finance ·
- Guggenheim initiates coverage of Yarrow Bioscience at Buy, sets price target at $60
TradingView ·
- Molson Coors downgraded, SiTime upgraded: Wall Street's top analyst calls
Yahoo Finance ·
- Yarrow Bioscience initiated with a Buy at Guggenheim
TipRanks ·
- Guggenheim initiates Yarrow Bioscience stock with buy rating
Investing.com ·
- Yarrow Bioscience stock: Three November investor events ahead
ad-hoc-news.de ·
- Yarrow Bioscience Announces Participation in November Investor Events
Yahoo Finance ·
- Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Yahoo Finance ·
- Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
Yahoo Finance ·
- Yarrow Bioscience Announces Proposed Underwritten Public Offering
Yahoo Finance ·
Yarrow Bioscience, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $570,000 | $501,000 | $424,000 | $477,000 |
| Net income | -$26.5M | -$39.8M | -$28.5M | -$23.2M |
| Diluted EPS | $-0.62 | $-0.93 | $-2.78 | $-7.28 |
| Total assets (year end) | $30.2M | $66.9M | $97.7M | $40.8M |
| Cash and equivalents (year end) | $24.0M | $19.9M | $30.6M | $30.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Yarrow Bioscience, Inc.
- Ticker
- YARW (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, CT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1566044
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc.
Frequently asked questions
What exchange is Yarrow Bioscience, Inc. listed on?
Yarrow Bioscience, Inc. trades on the Nasdaq under the ticker symbol YARW.
What industry is Yarrow Bioscience, Inc. in?
Yarrow Bioscience, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Yarrow Bioscience, Inc. headquartered?
Yarrow Bioscience, Inc.'s business address on file with the SEC is in New Haven, CT.
When does Yarrow Bioscience, Inc.'s fiscal year end?
Yarrow Bioscience, Inc.'s fiscal year ends on December 31.
How much revenue did Yarrow Bioscience, Inc. report?
Yarrow Bioscience, Inc. reported $570,000 in revenue for calendar year 2025, according to its SEC filings.